FOR IMMEDIATE RELEASE: May 8, 2018 Contact: Chris Angermayer, CEO (626) 460- 3050 [email protected] Investment capital will enable SeqOnce to…
By: Kevin Smith Pasadena has long been a mecca for tech firms and startups but the city’s bioscience industry is…
March 5, 2018 – We are thrilled! Out of 13 companies that pitched at UCLA, Deton was chosen as the…
The California Biotechnology Foundation recently hosted two Biotech 101 legislative staff briefings in San Diego and Pasadena on California’s Life…
July 20th, 2017 Deton Corp. has been awarded a $225,000 National Institute of Health (NIH) Small Business Innovation Research (SBIR)…